BURLINGAME, Calif. (AP) _ Kindred Biosciences Inc. (KIN) on Thursday reported a loss of $16.1 million in its first quarter.
On a per-share basis, the Burlingame, California-based company said it had a loss of 42 cents.
The biopharmaceutical company posted revenue of $515,000 in the period.
Kindred Bio shares have dropped 18% since the beginning of the year. In the final minutes of trading on Thursday, shares hit $8.97, a decline of 7% in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on KIN at https://www.zacks.com/ap/KIN